Researchers identify biomarkers for checkpoint inhibitor-induced hyperprogression of melanoma cells
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression ...